The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Immunotherapy Drugs-Global Market Insights and Sales Trends 2024
Synopsis
Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system.
The global Immunotherapy Drugs market size is expected to reach US$ 404130 million by 2029, growing at a CAGR of 10.6% from 2023 to 2029. The market is mainly driven by the significant applications of Immunotherapy Drugs in various end use industries. The expanding demands from the Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases and Others, are propelling Immunotherapy Drugs market. Monoclonal Antibodies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Adult Vaccines segment is estimated at % CAGR for the next seven-year period.
North America is expected to account for largest share in the immunotherapy drugs market, by region in 2018. Asia-Pacific is expected to be the fastest-growing regional segment in the market. The high growth of this segment can primarily be attributed to the low cost of manufacturing and acceptable regulatory scenario in this region.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immunotherapy Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immunotherapy Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immunotherapy Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immunotherapy Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immunotherapy Drugs covered in this report include Roche, Merck, Novartis, Johnson & Johnson, Glaxosmithkline, Amgen, Abbvie, Astrazeneca and Bristol-Myers Squibb, etc.
The global Immunotherapy Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Merck
Novartis
Johnson & Johnson
Glaxosmithkline
Amgen
Abbvie
Astrazeneca
Bristol-Myers Squibb
ELI Lilly
Global Immunotherapy Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immunotherapy Drugs market, Segment by Type:
Monoclonal Antibodies
Adult Vaccines
Checkpoint Inhibitors
Interferons Alpha & Beta
Interleukins
Others
Global Immunotherapy Drugs market, by Application
Cancer
Autoimmune & Inflammatory Diseases
Infectious Diseases
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Immunotherapy Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system.
The global Immunotherapy Drugs market size is expected to reach US$ 404130 million by 2029, growing at a CAGR of 10.6% from 2023 to 2029. The market is mainly driven by the significant applications of Immunotherapy Drugs in various end use industries. The expanding demands from the Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases and Others, are propelling Immunotherapy Drugs market. Monoclonal Antibodies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Adult Vaccines segment is estimated at % CAGR for the next seven-year period.
North America is expected to account for largest share in the immunotherapy drugs market, by region in 2018. Asia-Pacific is expected to be the fastest-growing regional segment in the market. The high growth of this segment can primarily be attributed to the low cost of manufacturing and acceptable regulatory scenario in this region.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immunotherapy Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immunotherapy Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immunotherapy Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immunotherapy Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immunotherapy Drugs covered in this report include Roche, Merck, Novartis, Johnson & Johnson, Glaxosmithkline, Amgen, Abbvie, Astrazeneca and Bristol-Myers Squibb, etc.
The global Immunotherapy Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Merck
Novartis
Johnson & Johnson
Glaxosmithkline
Amgen
Abbvie
Astrazeneca
Bristol-Myers Squibb
ELI Lilly
Global Immunotherapy Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immunotherapy Drugs market, Segment by Type:
Monoclonal Antibodies
Adult Vaccines
Checkpoint Inhibitors
Interferons Alpha & Beta
Interleukins
Others
Global Immunotherapy Drugs market, by Application
Cancer
Autoimmune & Inflammatory Diseases
Infectious Diseases
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Immunotherapy Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Immunotherapy Drugs
1.1 Immunotherapy Drugs Market Overview
1.1.1 Immunotherapy Drugs Product Scope
1.1.2 Immunotherapy Drugs Market Status and Outlook
1.2 Global Immunotherapy Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Immunotherapy Drugs Market Size by Region (2018-2029)
1.4 Global Immunotherapy Drugs Historic Market Size by Region (2018-2023)
1.5 Global Immunotherapy Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Immunotherapy Drugs Market Size (2018-2029)
1.6.1 North America Immunotherapy Drugs Market Size (2018-2029)
1.6.2 Europe Immunotherapy Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Immunotherapy Drugs Market Size (2018-2029)
1.6.4 Latin America Immunotherapy Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Immunotherapy Drugs Market Size (2018-2029)
2 Immunotherapy Drugs Market by Type
2.1 Introduction
2.1.1 Monoclonal Antibodies
2.1.2 Adult Vaccines
2.1.3 Checkpoint Inhibitors
2.1.4 Interferons Alpha & Beta
2.1.5 Interleukins
2.1.6 Others
2.2 Global Immunotherapy Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Immunotherapy Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Immunotherapy Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Immunotherapy Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Immunotherapy Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Immunotherapy Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Immunotherapy Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Immunotherapy Drugs Revenue Breakdown by Type (2018-2029)
3 Immunotherapy Drugs Market Overview by Application
3.1 Introduction
3.1.1 Cancer
3.1.2 Autoimmune & Inflammatory Diseases
3.1.3 Infectious Diseases
3.1.4 Others
3.2 Global Immunotherapy Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Immunotherapy Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Immunotherapy Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Immunotherapy Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Immunotherapy Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Immunotherapy Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Immunotherapy Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Immunotherapy Drugs Revenue Breakdown by Application (2018-2029)
4 Immunotherapy Drugs Competition Analysis by Players
4.1 Global Immunotherapy Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immunotherapy Drugs as of 2022)
4.3 Date of Key Players Enter into Immunotherapy Drugs Market
4.4 Global Top Players Immunotherapy Drugs Headquarters and Area Served
4.5 Key Players Immunotherapy Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Immunotherapy Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Immunotherapy Drugs Products, Services and Solutions
5.1.4 Roche Immunotherapy Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Recent Developments
5.2 Merck
5.2.1 Merck Profile
5.2.2 Merck Main Business
5.2.3 Merck Immunotherapy Drugs Products, Services and Solutions
5.2.4 Merck Immunotherapy Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Recent Developments
5.3 Novartis
5.3.1 Novartis Profile
5.3.2 Novartis Main Business
5.3.3 Novartis Immunotherapy Drugs Products, Services and Solutions
5.3.4 Novartis Immunotherapy Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 Johnson & Johnson Recent Developments
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Profile
5.4.2 Johnson & Johnson Main Business
5.4.3 Johnson & Johnson Immunotherapy Drugs Products, Services and Solutions
5.4.4 Johnson & Johnson Immunotherapy Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 Johnson & Johnson Recent Developments
5.5 Glaxosmithkline
5.5.1 Glaxosmithkline Profile
5.5.2 Glaxosmithkline Main Business
5.5.3 Glaxosmithkline Immunotherapy Drugs Products, Services and Solutions
5.5.4 Glaxosmithkline Immunotherapy Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Glaxosmithkline Recent Developments
5.6 Amgen
5.6.1 Amgen Profile
5.6.2 Amgen Main Business
5.6.3 Amgen Immunotherapy Drugs Products, Services and Solutions
5.6.4 Amgen Immunotherapy Drugs Revenue (US$ Million) & (2018-2023)
5.6.5 Amgen Recent Developments
5.7 Abbvie
5.7.1 Abbvie Profile
5.7.2 Abbvie Main Business
5.7.3 Abbvie Immunotherapy Drugs Products, Services and Solutions
5.7.4 Abbvie Immunotherapy Drugs Revenue (US$ Million) & (2018-2023)
5.7.5 Abbvie Recent Developments
5.8 Astrazeneca
5.8.1 Astrazeneca Profile
5.8.2 Astrazeneca Main Business
5.8.3 Astrazeneca Immunotherapy Drugs Products, Services and Solutions
5.8.4 Astrazeneca Immunotherapy Drugs Revenue (US$ Million) & (2018-2023)
5.8.5 Astrazeneca Recent Developments
5.9 Bristol-Myers Squibb
5.9.1 Bristol-Myers Squibb Profile
5.9.2 Bristol-Myers Squibb Main Business
5.9.3 Bristol-Myers Squibb Immunotherapy Drugs Products, Services and Solutions
5.9.4 Bristol-Myers Squibb Immunotherapy Drugs Revenue (US$ Million) & (2018-2023)
5.9.5 Bristol-Myers Squibb Recent Developments
5.10 ELI Lilly
5.10.1 ELI Lilly Profile
5.10.2 ELI Lilly Main Business
5.10.3 ELI Lilly Immunotherapy Drugs Products, Services and Solutions
5.10.4 ELI Lilly Immunotherapy Drugs Revenue (US$ Million) & (2018-2023)
5.10.5 ELI Lilly Recent Developments
6 North America
6.1 North America Immunotherapy Drugs Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Immunotherapy Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Immunotherapy Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Immunotherapy Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Immunotherapy Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Immunotherapy Drugs Market Dynamics
11.1 Immunotherapy Drugs Industry Trends
11.2 Immunotherapy Drugs Market Drivers
11.3 Immunotherapy Drugs Market Challenges
11.4 Immunotherapy Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
